Model Medicines launches oncology programs targeting AXL and BRD4

Newsroom

Model Medicines launches oncology programs targeting AXL and BRD4

Lani Nguyen 10/6/22 Lani Nguyen 10/6/22

Model Medicines launches oncology programs targeting AXL and BRD4

Scripps Research, Model Medicines Partner to Develop COVID-19 Therapeutics

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Scripps Research, Model Medicines Partner to Develop COVID-19 Therapeutics

Model Medicines partnered with LEO Pharma to accelerate drug discovery

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines partnered with LEO Pharma to accelerate drug discovery

Model Medicines partnered with LEO Pharma to accelerate drug discovery

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines partnered with LEO Pharma to accelerate drug discovery

AI drug discovery startup strikes partnership with LEO Pharma

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

AI drug discovery startup strikes partnership with LEO Pharma

Model Medicines is betting its high-powered algorithms can speed up drug discovery

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines is betting its high-powered algorithms can speed up drug discovery

Model Medicines, Scripps collaborate on COVID-19 drug discovery

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Model Medicines, Scripps collaborate on COVID-19 drug discovery

AI May Be Used to Find New Cures in Old Drugs

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

AI May Be Used to Find New Cures in Old Drugs

Accelerator-Backed Startups Find COVID-19 Opportunities

Lani Nguyen 9/21/21 Lani Nguyen 9/21/21

Accelerator-Backed Startups Find COVID-19 Opportunities

Model Medicines Highlighted as VC Backed StartUp Battling COVID-19 by MedCityNews

Lani Nguyen 3/29/20 Lani Nguyen 3/29/20

Model Medicines Highlighted as VC Backed StartUp Battling COVID-19 by MedCityNews

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Lani Nguyen 3/28/20 Lani Nguyen 3/28/20

Model Medicines COVID-19 Drug Development Program Highlighted by FreshBrewedTech

Model Medicines Executive Chairman & CTO discuss AI Drug Discovery at The Future of Digital Health Summit at JPM 2020 Healthcare Week

Model Medicines’ CHEMprint™ AI/ML drug discovery platform successfully identified multiple drug candidates that were found to be active against SARS-CoV-2 replication in a live virus study in a human cell line at a hit rate of over 14%.

“AI and ML models... can significantly improve the efficacy of drug discovery.”

Arnab Chatterjee, Ph.D
Calibr at Scripps Research

“We are very pleased with the demonstrated potent antiviral activity of MDL-001.”

Davey Smith, MDUC
San Diego Health

“We are very excited to partner with Model Medicines on this important endeavor to identify novel therapeutics to treat the immediate threat of SARS-CoV-2 today and prepare for the pandemics of tomorrow.”

Sumit Chanda, Ph.D.
Sanford Burnham Prebys

“...a game-changer in the global fight against COVID-19.”

Adolfo Garcia-Sastre, Ph.D
Icahn School of Medicine at Mount Sinai